A case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain

Takahisa Tateishi, Kimihiro Tanaka, Yoshikiyo Ito, Kunihiko Mitsuo

Research output: Contribution to journalArticle

Abstract

We reported a case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain and lungs. A 21-year-old man was admitted because of one month history of low grade fever, headache, nausea, and amnesia. He developed agammaglobulinemia following Epstein-Barr virus infection at 3-year-old, and thereafter was administered 7.5g of immunoglobulin every 3 weeks with a diagnosis of XLP. Physical examination was unremarkable on admission. Neurological examination revealed disorientation of time, and bilateral gaze-evoked nystagmus. Neuropsychological tests demonstrated impairment of recent memory and calculation. Pleocytosis (83/μl) and increase of protein (1,269mg/dl) and IgG (141mg/dl) in the CSF were observed. Brain MRI showed multiple nodular lesions with high intense signal on T2-weighted images and Gd-DTPA enhancement on T1-weighted images. Chest CT showed multiple nodular lesions in the bilateral lungs. The needle lung biopsy was performed, which showed infiltration of lymphocytes around the vessels. An immunohistochemical study showed that the infiltrating cells were mainly CD8 positive T lymphocytes. B lymphocyte and plasma cells were not seen. The histological findings excluded intravascular malignant lymphoma and lymphomatoid granulomatosis. Therefore we diagnosed lymphoid vasculitis. The patient developed pancytopenia caused by hemophagocytic syndrome 48 days after admission and was treated with l g of methylprednisolone per day for 3 days and a tapered dose of steroid (500mg to 125mg of methylprednisolone and 60mg to 10mg of predonisolone) for 21 days, which resulted in the improvement of clinical features (hemophagocytic syndrome and central nervous system symptoms) and the abnormal CSF findings. The multiple nodular lesions in the brain and the lungs shrank 1 month after treatment and disappeared 11 months later. There are few reports concerning lymphoid vasculitis with XLP, and no effective treatment has been described. Our case suggests that steroid therapy may be useful for the treatment of lymphoid vasculitis in XLP.

Original languageEnglish
Pages (from-to)254-260
Number of pages7
JournalClinical Neurology
Volume46
Issue number4
Publication statusPublished - Apr 2006
Externally publishedYes

Fingerprint

Lymphoproliferative Disorders
Vasculitis
Hemophagocytic Lymphohistiocytosis
Lung
Methylprednisolone
Brain
Lymphomatoid Granulomatosis
Steroids
CD8-Positive T-Lymphocytes
Agammaglobulinemia
Confusion
Gadolinium DTPA
Pancytopenia
Epstein-Barr Virus Infections
Amnesia
Neuropsychological Tests
Leukocytosis
Neurologic Examination
Needle Biopsy
Therapeutics

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

Tateishi, T., Tanaka, K., Ito, Y., & Mitsuo, K. (2006). A case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain. Clinical Neurology, 46(4), 254-260.

A case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain. / Tateishi, Takahisa; Tanaka, Kimihiro; Ito, Yoshikiyo; Mitsuo, Kunihiko.

In: Clinical Neurology, Vol. 46, No. 4, 04.2006, p. 254-260.

Research output: Contribution to journalArticle

Tateishi, T, Tanaka, K, Ito, Y & Mitsuo, K 2006, 'A case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain', Clinical Neurology, vol. 46, no. 4, pp. 254-260.
Tateishi, Takahisa ; Tanaka, Kimihiro ; Ito, Yoshikiyo ; Mitsuo, Kunihiko. / A case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain. In: Clinical Neurology. 2006 ; Vol. 46, No. 4. pp. 254-260.
@article{bacd31cb0d544dd998203b4c0fad6b51,
title = "A case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain",
abstract = "We reported a case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain and lungs. A 21-year-old man was admitted because of one month history of low grade fever, headache, nausea, and amnesia. He developed agammaglobulinemia following Epstein-Barr virus infection at 3-year-old, and thereafter was administered 7.5g of immunoglobulin every 3 weeks with a diagnosis of XLP. Physical examination was unremarkable on admission. Neurological examination revealed disorientation of time, and bilateral gaze-evoked nystagmus. Neuropsychological tests demonstrated impairment of recent memory and calculation. Pleocytosis (83/μl) and increase of protein (1,269mg/dl) and IgG (141mg/dl) in the CSF were observed. Brain MRI showed multiple nodular lesions with high intense signal on T2-weighted images and Gd-DTPA enhancement on T1-weighted images. Chest CT showed multiple nodular lesions in the bilateral lungs. The needle lung biopsy was performed, which showed infiltration of lymphocytes around the vessels. An immunohistochemical study showed that the infiltrating cells were mainly CD8 positive T lymphocytes. B lymphocyte and plasma cells were not seen. The histological findings excluded intravascular malignant lymphoma and lymphomatoid granulomatosis. Therefore we diagnosed lymphoid vasculitis. The patient developed pancytopenia caused by hemophagocytic syndrome 48 days after admission and was treated with l g of methylprednisolone per day for 3 days and a tapered dose of steroid (500mg to 125mg of methylprednisolone and 60mg to 10mg of predonisolone) for 21 days, which resulted in the improvement of clinical features (hemophagocytic syndrome and central nervous system symptoms) and the abnormal CSF findings. The multiple nodular lesions in the brain and the lungs shrank 1 month after treatment and disappeared 11 months later. There are few reports concerning lymphoid vasculitis with XLP, and no effective treatment has been described. Our case suggests that steroid therapy may be useful for the treatment of lymphoid vasculitis in XLP.",
author = "Takahisa Tateishi and Kimihiro Tanaka and Yoshikiyo Ito and Kunihiko Mitsuo",
year = "2006",
month = "4",
language = "English",
volume = "46",
pages = "254--260",
journal = "Clinical Neurology",
issn = "0009-918X",
publisher = "Societas Neurologica Japonica",
number = "4",

}

TY - JOUR

T1 - A case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain

AU - Tateishi, Takahisa

AU - Tanaka, Kimihiro

AU - Ito, Yoshikiyo

AU - Mitsuo, Kunihiko

PY - 2006/4

Y1 - 2006/4

N2 - We reported a case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain and lungs. A 21-year-old man was admitted because of one month history of low grade fever, headache, nausea, and amnesia. He developed agammaglobulinemia following Epstein-Barr virus infection at 3-year-old, and thereafter was administered 7.5g of immunoglobulin every 3 weeks with a diagnosis of XLP. Physical examination was unremarkable on admission. Neurological examination revealed disorientation of time, and bilateral gaze-evoked nystagmus. Neuropsychological tests demonstrated impairment of recent memory and calculation. Pleocytosis (83/μl) and increase of protein (1,269mg/dl) and IgG (141mg/dl) in the CSF were observed. Brain MRI showed multiple nodular lesions with high intense signal on T2-weighted images and Gd-DTPA enhancement on T1-weighted images. Chest CT showed multiple nodular lesions in the bilateral lungs. The needle lung biopsy was performed, which showed infiltration of lymphocytes around the vessels. An immunohistochemical study showed that the infiltrating cells were mainly CD8 positive T lymphocytes. B lymphocyte and plasma cells were not seen. The histological findings excluded intravascular malignant lymphoma and lymphomatoid granulomatosis. Therefore we diagnosed lymphoid vasculitis. The patient developed pancytopenia caused by hemophagocytic syndrome 48 days after admission and was treated with l g of methylprednisolone per day for 3 days and a tapered dose of steroid (500mg to 125mg of methylprednisolone and 60mg to 10mg of predonisolone) for 21 days, which resulted in the improvement of clinical features (hemophagocytic syndrome and central nervous system symptoms) and the abnormal CSF findings. The multiple nodular lesions in the brain and the lungs shrank 1 month after treatment and disappeared 11 months later. There are few reports concerning lymphoid vasculitis with XLP, and no effective treatment has been described. Our case suggests that steroid therapy may be useful for the treatment of lymphoid vasculitis in XLP.

AB - We reported a case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain and lungs. A 21-year-old man was admitted because of one month history of low grade fever, headache, nausea, and amnesia. He developed agammaglobulinemia following Epstein-Barr virus infection at 3-year-old, and thereafter was administered 7.5g of immunoglobulin every 3 weeks with a diagnosis of XLP. Physical examination was unremarkable on admission. Neurological examination revealed disorientation of time, and bilateral gaze-evoked nystagmus. Neuropsychological tests demonstrated impairment of recent memory and calculation. Pleocytosis (83/μl) and increase of protein (1,269mg/dl) and IgG (141mg/dl) in the CSF were observed. Brain MRI showed multiple nodular lesions with high intense signal on T2-weighted images and Gd-DTPA enhancement on T1-weighted images. Chest CT showed multiple nodular lesions in the bilateral lungs. The needle lung biopsy was performed, which showed infiltration of lymphocytes around the vessels. An immunohistochemical study showed that the infiltrating cells were mainly CD8 positive T lymphocytes. B lymphocyte and plasma cells were not seen. The histological findings excluded intravascular malignant lymphoma and lymphomatoid granulomatosis. Therefore we diagnosed lymphoid vasculitis. The patient developed pancytopenia caused by hemophagocytic syndrome 48 days after admission and was treated with l g of methylprednisolone per day for 3 days and a tapered dose of steroid (500mg to 125mg of methylprednisolone and 60mg to 10mg of predonisolone) for 21 days, which resulted in the improvement of clinical features (hemophagocytic syndrome and central nervous system symptoms) and the abnormal CSF findings. The multiple nodular lesions in the brain and the lungs shrank 1 month after treatment and disappeared 11 months later. There are few reports concerning lymphoid vasculitis with XLP, and no effective treatment has been described. Our case suggests that steroid therapy may be useful for the treatment of lymphoid vasculitis in XLP.

UR - http://www.scopus.com/inward/record.url?scp=33744954072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744954072&partnerID=8YFLogxK

M3 - Article

VL - 46

SP - 254

EP - 260

JO - Clinical Neurology

JF - Clinical Neurology

SN - 0009-918X

IS - 4

ER -